Lancet Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Lancet Market
1.1. Definition and Scope
1.1.1. Definition of Lancet
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Lancet Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Lancet Market By Type
1.2.3. Lancet Market By Size
1.2.4. Lancet Market By End-use
1.2.5. Lancet Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Lancet Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Lancet Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Lancet Market By Type
5.1. Introduction
5.2. Lancet Revenue By Type
5.2.1. Lancet Revenue (USD Billion) and Forecast, By Type, 2020-2032
5.2.2. Safety lancets
5.2.2.1. Safety lancets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Manually activated lancets
5.2.3.1. Manually activated lancets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Automatically activated lancets
5.2.4.1. Automatically activated lancets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Standard lancets
5.2.5.1. Standard lancets Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Lancet Market By Size
6.1. Introduction
6.2. Lancet Revenue By Size
6.2.1. Lancet Revenue (USD Billion) and Forecast, By Size, 2020-2032
6.2.2. 22G and below
6.2.2.1. 22G and below Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. 23G-33G
6.2.3.1. 23G-33G Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Above 33G
6.2.4.1. Above 33G Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Lancet Market By End-use
7.1. Introduction
7.2. Lancet Revenue By End-use
7.2.1. Lancet Revenue (USD Billion) and Forecast, By End-use, 2020-2032
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Clinics
7.2.3.1. Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Ambulatory surgical centers
7.2.4.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Homecare settings
7.2.5.1. Homecare Settings Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.6. Others
7.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Lancet Market By Country
8.1. North America Lancet Market Overview
8.2. U.S.
8.2.1. U.S. Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
8.2.2. U.S. Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
8.2.3. U.S. Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
8.3. Canada
8.3.1. Canada Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
8.3.2. Canada Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
8.3.3. Canada Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Lancet Market By Country
9.1. Europe Lancet Market Overview
9.2. U.K.
9.2.1. U.K. Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.2. U.K. Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
9.2.3. U.K. Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.3. Germany
9.3.1. Germany Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.2. Germany Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
9.3.3. Germany Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.4. France
9.4.1. France Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
9.4.2. France Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
9.4.3. France Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.5. Spain
9.5.1. Spain Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
9.5.2. Spain Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
9.5.3. Spain Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
9.6.2. Rest of Europe Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
9.6.3. Rest of Europe Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Lancet Market By Country
10.1. Asia Pacific Lancet Market Overview
10.2. China
10.2.1. China Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.2. China Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
10.2.3. China Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.3. Japan
10.3.1. Japan Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.2. Japan Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
10.3.3. Japan Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.4. India
10.4.1. India Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.2. India Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
10.4.3. India Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.5. Australia
10.5.1. Australia Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
10.5.2. Australia Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
10.5.3. Australia Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.6. South Korea
10.6.1. South Korea Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
10.6.2. South Korea Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
10.6.3. South Korea Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
10.7.2. Rest of Asia-Pacific Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
10.7.3. Rest of Asia-Pacific Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Lancet Market By Country
11.1. Latin America Lancet Market Overview
11.2. Brazil
11.2.1. Brazil Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.2. Brazil Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
11.2.3. Brazil Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.3. Mexico
11.3.1. Mexico Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.2. Mexico Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
11.3.3. Mexico Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.2. Rest of Latin America Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
11.4.3. Rest of Latin America Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Lancet Market By Country
12.1. Middle East & Africa Lancet Market Overview
12.2. GCC
12.2.1. GCC Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
12.2.2. GCC Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
12.2.3. GCC Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.3. South Africa
12.3.1. South Africa Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
12.3.2. South Africa Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
12.3.3. South Africa Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Lancet Revenue (USD Billion) and Forecast By Type, 2020-2032
12.4.2. Rest of Middle East & Africa Lancet Revenue (USD Billion) and Forecast By Size, 2020-2032
12.4.3. Rest of Middle East & Africa Lancet Revenue (USD Billion) and Forecast By End-use, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Lancet Market
13.1. Lancet Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Lancet Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. AgaMatrix
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. AgaMatrix 2022 Lancet Business Regional Distribution
14.1.4. Product/Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. All Medicus Co. Ltd.
14.3. Abbott Laboratories
14.4. B. Braun Melsungen AG
14.5. Ascensia Diabetes Care Holdings AG
14.6. Dexcom, Inc.
14.7. Arkray, Inc
14.8. Bionime Corporation
14.9. LifeScan Inc.
14.10. DarioHealth Corp.
14.11. Essenlife Bioscience, Inc.
14.12. Nova Biomedical, Inc.
14.13. F. Hoffmann-La Roche Ltd.
14.14. Medtronic
14.15. Sinocare Inc.
Frequently Asked Questions
What was the market size of the global lancet in 2022?
The market size of lancet was USD 1.4 Billion in 2022.
What is the CAGR of the global lancet market from 2023 to 2032?
The CAGR of lancet is 9.5% during the analysis period of 2023 to 2032.
Which are the key players in the lancet market?
The key players operating in the global market are including AgaMatrix, All Medicus Co. Ltd., Abbott Laboratories, B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., Arkray, Inc, Bionime Corporation, LifeScan Inc., DarioHealth Corp., Essenlife Bioscience, Inc., Nova Biomedical, Inc., F. Hoffmann-La Roche Ltd., Medtronic, and Sinocare Inc.
Which region dominated the global lancet market share?
North America held the dominating position in lancet industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of lancet during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global lancet industry?
The current trends and dynamics in the lancet industry include growing global healthcare expenditure, increasing prevalence of chronic diseases, and technological advancements in medical equipment.
Which size held the maximum share in 2022?
The 23G-33G size held the maximum share of the lancet industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
